Note 12 - Segment Information

12 Months Ended

Jun. 30, 2012

Segment Reporting Disclosure [Text Block]

12. SEGMENT INFORMATION

The Company has four distinct product lines:  Medication Management systems, Blood and Biologics Management systems, Performance Management systems and Perioperative Management systems.   Based on similar economic characteristics, as well as the nature of products, production processes, customers and distribution methods, the Company has aggregated these four product lines into one reporting segment.  Revenues by product line are as follows (in thousands):

	For the Twelve Months Ended June 30,
	2012		2011		2010
Medication Management Systems:
System sales	$	7,532	$	7,855	$	5,742
Services		22,194		19,517		17,889
Billing and collections		4,513		4,109		2,084
		34,239		31,481		25,715
Blood and Biologics Management Systems:
System sales		9,077		6,161		4,580
Services		18,743		15,738		14,748
		27,820		21,899		19,328
Performance Management Systems:
System sales		1,011		397		541
Services		911		1,049		1,166
		1,922		1,446		1,707
Perioperative Management Systems:
System sales		-		-		55
Services		620		697		811
		620		697		866
Total	$	64,601	$	55,523	$	47,616

Billing and collections revenue is generated from ARL and to a lesser extent, certain assets of CareCentric.  Revenue from one customer represented approximately 14% of Mediware’s consolidated revenue for the year ended June 30, 2012.  No customer accounted for more than 10% of revenues during fiscal 2011 and 2010.

Selected financial information by geographic area is as follows (in thousands):

	For the Year Ended June 30,
	2012		2011		2010
Revenue:
United States	$	57,772	$	48,774	$	41,269
Europe		6,829		6,749		6,347
Total	$	64,601	$	55,523	$	47,616
Net Income (Loss):
United States	$	7,297	$	5,491	$	2,423
Europe		248		801		819
Total	$	7,545	$	6,292	$	3,242

	As of June 30,
	2012		2011
Total Assets:
United States	$	83,779	$	77,815
Europe		9,415		8,995
Total	$	93,194	$	86,810